Protagonist Therapeutics Inc
Follow $PTGX
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $PTGX by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is PTGX moving today?
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
PTGX overview
Related filings and maps
Congress activity in PTGX
No receipt-qualified Congressional disclosure is present for PTGX in the cached public ledger.
PTGX contract awards, year to date.
Public federal awards linked to this ticker.
PTGX lobbying filings, year to date.
Registered lobbying filings matched to Protagonist Therapeutics Inc.